Suppr超能文献

载脂蛋白 AIV 需要胆囊收缩素和迷走神经来抑制食欲。

Apolipoprotein AIV requires cholecystokinin and vagal nerves to suppress food intake.

机构信息

Departments of Pathology and Laboratory Medicine, Cincinnati, OH 45237-0507, USA.

出版信息

Endocrinology. 2012 Dec;153(12):5857-65. doi: 10.1210/en.2012-1427. Epub 2012 Oct 1.

Abstract

Apolipoprotein AIV (apo AIV) and cholecystokinin (CCK) are gastrointestinal satiation signals that are stimulated by fat consumption. Previous studies have demonstrated that peripheral apo AIV cannot cross the blood-brain barrier. In the present study, we hypothesized that peripheral apo AIV uses a CCK-dependent system and intact vagal nerves to relay its satiation signal to the hindbrain. To test this hypothesis, CCK-knockout (CCK-KO) mice and Long-Evan rats that had undergone subdiaphragmatic vagal deafferentation (SDA) were used. Intraperitoneal administration of apo AIV at 100 or 200 μg/kg suppressed food intake of wild-type (WT) mice at 30, 60, and 90 min. In contrast, the same dose did not reduce food intake in the CCK-KO mice. Blockade of the CCK 1 receptor by lorglumide, a CCK 1 receptor antagonist, attenuated apo AIV-induced satiation. Apo AIV at 100 μg/kg reduced food intake in SHAM rats but not in SDA rats. Furthermore, apo AIV elicited an increase in c-Fos-positive cells in the nucleus of the solitary tract (NTS), area postrema, dorsal motor nucleus of the vagus, and adjacent areas of WT mice but elicited only an attenuated increase in these same regions in CCK-KO mice. Apo AIV-induced c-Fos positive cells in the NTS and area postrema of WT mice were reduced by lorglumide. Lastly, apo AIV increased c-Fos positive cells in the NTS of SHAM rats but not in SDA rats. These observations imply that peripheral apo AIV requires an intact CCK system and vagal afferents to activate neurons in the hindbrain to reduce food intake.

摘要

载脂蛋白 AIV(apo AIV)和胆囊收缩素(CCK)是受脂肪摄入刺激的胃肠道饱腹感信号。先前的研究表明,外周 apo AIV 不能穿过血脑屏障。在本研究中,我们假设外周 apo AIV 使用 CCK 依赖性系统和完整的迷走神经将其饱腹感信号传递到后脑。为了验证这一假设,使用了 CCK 敲除(CCK-KO)小鼠和接受膈下迷走神经切断术(SDA)的 Long-Evan 大鼠。腹腔给予 apo AIV 100 或 200μg/kg,可抑制野生型(WT)小鼠在 30、60 和 90 分钟时的摄食量。相比之下,相同剂量不会减少 CCK-KO 小鼠的食物摄入量。CCK1 受体拮抗剂 lorglumide 阻断 CCK1 受体可减弱 apo AIV 诱导的饱腹感。100μg/kg apo AIV 可减少 SHAM 大鼠的食物摄入量,但不能减少 SDA 大鼠的食物摄入量。此外,apo AIV 可引起 WT 小鼠孤束核(NTS)、迷走神经后根、迷走神经背核和相邻区域中 c-Fos 阳性细胞增加,但在 CCK-KO 小鼠中仅引起这些相同区域的 c-Fos 阳性细胞增加减弱。Lorglumide 可减少 WT 小鼠 NTS 和迷走神经后根中 apo AIV 诱导的 c-Fos 阳性细胞。最后,apo AIV 可增加 SHAM 大鼠 NTS 中的 c-Fos 阳性细胞,但不能增加 SDA 大鼠 NTS 中的 c-Fos 阳性细胞。这些观察结果表明,外周 apo AIV 需要完整的 CCK 系统和迷走神经传入来激活后脑神经元以减少食物摄入。

相似文献

5
Interaction of apolipoprotein AIV with cholecystokinin on the control of food intake.载脂蛋白AIV与胆囊收缩素在食物摄入控制方面的相互作用。
Am J Physiol Regul Integr Comp Physiol. 2007 Oct;293(4):R1490-4. doi: 10.1152/ajpregu.00329.2007. Epub 2007 Jul 18.

引用本文的文献

1
Gut Hormones and Inflammatory Bowel Disease.肠道激素与炎症性肠病
Biomolecules. 2025 Jul 14;15(7):1013. doi: 10.3390/biom15071013.
9
Apolipoprotein A-IV enhances cholecystokinnin secretion.载脂蛋白A-IV可增强胆囊收缩素的分泌。
Physiol Behav. 2018 May 1;188:11-17. doi: 10.1016/j.physbeh.2018.01.019. Epub 2018 Jan 31.

本文引用的文献

2
Cholecystokinin.胆囊收缩素。
Curr Opin Endocrinol Diabetes Obes. 2012 Feb;19(1):8-12. doi: 10.1097/MED.0b013e32834eb77d.
6
Gut peptides in the control of food intake.肠道肽在食物摄入控制中的作用。
Int J Obes (Lond). 2009 Apr;33 Suppl 1:S7-10. doi: 10.1038/ijo.2009.9.
9
Characterization of mice lacking the gene for cholecystokinin.缺乏胆囊收缩素基因的小鼠的特征描述。
Am J Physiol Regul Integr Comp Physiol. 2008 Mar;294(3):R803-10. doi: 10.1152/ajpregu.00682.2007. Epub 2007 Dec 26.
10
Interaction of apolipoprotein AIV with cholecystokinin on the control of food intake.载脂蛋白AIV与胆囊收缩素在食物摄入控制方面的相互作用。
Am J Physiol Regul Integr Comp Physiol. 2007 Oct;293(4):R1490-4. doi: 10.1152/ajpregu.00329.2007. Epub 2007 Jul 18.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验